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Abstract: This study aims to synthesize the literature on any disproportionate health risks or con-
sequences of a COVID-19 infection for people with disabilities. Scoping review with a descriptive
thematic analysis was carried out. Up to mid-September 2020, seven scientific databases and three
preprint servers were searched to identify empirical or perspective papers. Snowballing searches
and expert’ consultations also took place. Two independent reviewers were used for the screenings
and data extractions. Of 1027 references, 58 were included, 15 of which were empirical articles. The
thematic analysis showed that: (1) People with disabilities living in residential or long-term care
facilities were more likely to have greater infection rates; (2) Intersecting mediators of greater infection
risks were multiple (e.g., lack of accessible information); (3) People with disabilities often face greater
health problems when infected; and (4) Unethical disadvantages in the rationing of lifesaving and
critical care can be experienced by people with disabilities. Conclusions: Beyond any health-related
vulnerabilities (e.g., comorbidity rates), multiple yet modifiable environmental factors can provide
disproportionate health risks and consequences of a COVID-19 infection for people with disabilities.
Public health and policy measures must prevent or reduce modifiable environmental risks.
Keywords: COVID-19; health equity; disabled persons; vulnerable populations; public health
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1. Introduction
The Corona Virus Disease 2019 (COVID-19) refers to a recent infectious disease that
has been causing major public health and economic crises worldwide. However, during
the pandemic, concerns have been raised that the health and socio-economic impact of the
pandemic may hit harder on some strata of the population, especially the most socially
vulnerable (e.g., low-income, institutionalized, incarcerated, refugees, those without access to
soap or clean water), and thereby can exacerbate existing health and social disparities [1–5].
People with disabilities refer to a group of people vulnerable to discrimination,
marginalization, and multiple social disadvantages [6,7]. These include vastly documented
disparities experienced in health, healthcare access, and healthcare quality and outcomes,
observed before the pandemic [8–10]. Historically, ‘ableism’ has dominated the way people
with disabilities have been perceived, including legal, political, educational practices, and
healthcare discourses that exclude and/or discriminate against people with disabilities, and
which result in disvaluing their lives [11]. These systematic values can put health equity for
people with disabilities in jeopardy during a pandemic crisis and unethically interfere with
any medical rationing decisions [12,13]. All accounted, COVID-19 has amplified existing
structural inequalities in health and the social determinants of health that many people
with disabilities have been facing for a long time [7,12].
People with disabilities are approached here as a ‘vulnerable group’ not because
people with disabilities are inherently vulnerable (which could enforce, and misleadingly
so, an ideal of normalcy), but mostly due to underlying ableist structural factors that result
in vulnerability, often arising from disability stigma, marginalization, and lack of societal
accommodations. These include the lack of disability-inclusive public health and health
systems’ responses. Indeed, the lack of disability inclusion in society and in public health to
design equitable healthcare policies is well documented by now [1,4,13,14]. Overall, aligned
with others [6,7,15–17], this literature review is developed from the standpoint that public
health and policy responses to the COVID-19 pandemic should be disability-inclusive [18].
It is expected that those special vulnerabilities experienced by people with disabilities
during the COVID-19 pandemic could result in greater exposure to or risks of being
infected, not having timely access to a COVID-19 diagnosis or treatment once infected
or experiencing more frequent or severe health and socio-economic consequences, either
being infected or not. Within the context of these possibilities, we have planned to develop
a scoping review of the literature addressing any, and often multiple, vulnerabilities faced
by people with disabilities during the COVID-19 pandemic [18].
This paper refers to the first part of those scoping review results. Here, we aim
to synthesize the literature on any disproportionate health risks or consequences of a
COVID-19 infection for people with disabilities. By disproportionate health risks, we mean
any greater risks for people with disabilities to be infected with the COVID-19/SARS-
COV-2. By disproportionate health consequences, we mean any greater likelihood of
having more severe health consequences once being infected. The latter can arise from
any individual vulnerability (e.g., comorbid conditions) or the lack of equitable and timely
access to healthcare.
2. Methods
A scoping review methodology was used, following the methods described in the
published, open-access scoping review protocol [18]. In this paper, descriptive thematic
analysis, later detailed, is used to understand any disproportional health risks or conse-
quences of a COVID-19 infection for people with disabilities. In turn, a second results
paper [19] addresses the lockdown-related health and socio-economic disparities that peo-
ple with disabilities may experience during the COVID-19 pandemic, without necessarily
being infected. The Preferred Reporting Items for Systematic reviews and Meta-Analyses
extension for Scoping Reviews (PRISMA-ScR) were used to guide this report [20].
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2.1. Eligibility Criteria
We included peer-reviewed empirical or perspective papers (including editorials or
commentaries) or pre-print empirical studies explicitly addressing: (1) the COVID-19
disease or pandemic; (2) People with disabilities as a group, subgroup (e.g., based on
impairment type or underlying diagnostic condition), or related individual circumstances
as a pre-condition—i.e., excluding impairments arising only as a consequence of the
COVID-19 infection; and (3) an individual-level (e.g., health- or age-related) or social-level
(e.g., living condition, and income-related) vulnerability to a COVID-19 infection or its
health consequences.
This open-access study protocol provides working definitions of people with disabili-
ties and vulnerability, including a text-box with the possible individual (e.g., comorbidities)
and social-level vulnerabilities (e.g., suboptimal access to healthcare, and living in institu-
tional settings) to the effects of the COVID-19 pandemic, as a means to support eligibility
decisions [18]. There were not any geographic restrictions and papers in 6 languages (i.e.,
English, French, Spanish, Greek, Russian, and Portuguese) were considered; however,
although articles in languages other than English were detected by the searches, none fully
met the other eligibility criteria.
2.2. Information Sources and Search
Seven databases for the scientific, peer-reviewed literature (i.e., Medline/PubMed,
Web of Science–Core Collection, Scopus, AgeLine, PsycINFO, CINAHL, and ERIC) were
used to search. Searches were run in mid-July 2020 and repeated two months later, as
described in the study protocol [18]. Hence, we cover the literature up to mid-September
2020, which roughly equates to data and perspectives from the first wave of the COVID-19
pandemic. Three databases for preprint literature (i.e., MedRxiv, SocArXiv, and PsyArXiv)
were also searched, following the same process and dates. During the initial stages of the
COVID-19 pandemic, preprint databases have been hosting many studies that have not
yet reached peer-reviewed publications [21]. Furthermore, this option can help to avoid
the exclusion of studies with negative results which may be published less often or less
rapidly. Before the data charting, we searched for the peer-reviewed version of the included
preprints and have replaced the record whenever found. The full search strategies for each
of the scientific and preprint databases were provided as a supplementary appendix in the
open-access protocol [18], as here are reported in the Supplementary Material S1.
A snowballing search process (e.g., author tracking, and referenced sources) was also
conducted, using the included references to identify any additional records. Supplied
with a preliminary list of inclusions, members of the American Congress of Rehabilitation
Medicine’s International Networking Group and Refugee Empowerment Task Force were
also consulted as key informants to provide any additional references.
Although planned [18], we did not include elements of the grey literature (e.g., official
reports from international organizations). During the initial searches, we have found a liv-
ing repository of that literature, hosted by the United Nations. That freely accessible reposi-
tory (https://www.un.org/development/desa/disabilities/covid-19.html (Accessed date:
15 December 2020)) provides key grey literature resources from the United Nations, their
specialty agencies, and from partner institutions (e.g., Disabled Person’s Organizations)
alike. With this new information, and to produce timely results as intended [18], we
opted to exclude the grey literature and narrow the review coverage to the peer-reviewed
literature and preprint studies. An iterative development process is common in scoping
reviews, with some decisions—as long as justified and reported—taken as new informa-
tion comes by, since scoping reviews usually explore and map out initially unchartered
territories [22,23].
2.3. Selection Process
The abstract-and-titles screenings and the full-text assessments were made against the
eligibility criteria and were conducted by two independent reviewers (S.K. and S.B.), after
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pilot screenings with over 80% agreements, overseen by the leading review author (T.J.).
Any discrepancies were resolved through consensus or the leading author’s input.
2.4. Data Charting and Items
Following a coding structure elaborated by members of the research team, one author
(S.K.) extracted formal data elements (publication type, sources, geographies addressed),
with a random 5% verified by another (T.J.). Regarding the content of the literature
included, two independent reviewers (SK and SB) extracted text quotations on (1) any
added risk for, or (2) disproportionate consequences of a COVID-19 infection on people
with disabilities. These independent extractions were later paired for the qualitative data
synthesis, which was also informed by a brief synthesis of each paper developed by two
reviewers independently. Then, the Supplementary Material S2 provides the content of
these extractions after being merged (i.e., presented as the combined extractions of both
reviewers), as well as reviewers’ combined synthesis of each paper.
2.5. Critical Appraisal
No methodological quality assessments were performed as described in the study
protocol [18] and common in scoping reviews [22–24].
2.6. Synthesis of the Results
Simple descriptive statistics (e.g. counts, and percentages) are computed to provide
a summative, tabular description of the amount and range of the related literature, in-
cluding per publication type and source, country (or countries), or health conditions or
impairments addressed.
A descriptive thematic analysis was developed to synthesize the text quotations [25].
The protocol for the entire scoping review project [18] defines the use of thematic analysis
in full, sometimes labeled as a reflexive thematic analysis [25,26]. However, that was
essentially applied over the content presented in a subsequent paper [19], addressing the
more complex intersections among health, social, economic, or occupational injustices or
inequalities experienced by people with disabilities due to lockdown-related measures.
For the issues being reviewed here, we apply a descriptive thematic analysis, as we did
not formulate a new interpretive schema but essentially provided a thematic clustering of
the findings—for any disproportionate health risk or health consequence of a COVID-19
infection among people with disabilities.
Finally, as described in the study protocol [18], we took a final consultation stage.
Supplied with a preliminary version of the results and its discussion, members of the Amer-
ican Congress of Rehabilitation Medicine’s International Networking Group and Refugee
Empowerment Task Force had the opportunity to comment and provide improvement
suggestions over the preliminary results and their interpretation.
3. Results
Figure 1 provides the flowchart of this review. Out of 1027 unique references, 58 are
finally included in this analysis, i.e., report findings or rationales for any disproportionate
health risks or health consequences of a COVID-19 infection for people with disabilities.
The Supplementary Material S3 lists the 58 papers included.




Figure 1. PRISMA flowchart of the scoping review with thematic analysis. 
Table 1 reflects the distribution of the analyzed articles by publication type and 
source, by geographical focus, and finally by the health conditions or impairments ad-
dressed.  
Among the 58 papers included, 15 were empirical studies (two of which preprints), 
and the vast majority (73%) were non-empirical (e.g., perspective papers). Close to two-
thirds (63%) of the papers had no geographical focus (e.g., were applicable across loca-
tions). When they had a geographical focus, most (12 out of 19) addressed the United 
States of America (USA) or the United Kingdom (UK) context. More than half of the pa-
pers (56%) addressed people with disabilities overall (i.e., had no focus on specific health 
conditions or impairments).  
Table 1. Quantitative map of the literature analyzed. 
Characteristics n (%)  Citations 
Publications Type And Source 
Perspective papers (e.g., viewpoints, 
commentaries, essays, ethics/advocacy) 34 (58%) [12,13,16,27–57]  
Narrative summary/review (non-systematic) 3 (5%) [58–60] 
Framework or Experts recommendations 3 (5%) [3,61,62] 
Figure 1. PRISMA flowchart of the scoping review with thematic analysis.
Table 1 reflects the distribution of the analyzed articles by publication type and source,
by geographical focus, and finally by the health conditions or impairments addressed.
Among the 58 papers included, 15 were empirical studies (two of which preprints),
and the vast majority (73%) were non-empirical (e.g., perspective papers). Close to two-
thirds (63%) of the papers had no geographical focus (e.g., were applicable across locations).
When they had a geographical focus, most (12 out of 19) addressed the United States of
America (USA) or the United Kingdom (UK) context. More than half of the papers (56%)
addressed people with disabilities overall (i.e., had no focus on specific health conditions
or impairments).
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Table 1. Quantitative map of the literature analyzed.
Characteristics n (%) Citations
Publications Type And Source
Perspective papers (e.g., viewpoints, commentaries,
essays, ethics/advocacy) 34 (58%) [12,13,16,27–57]
Narrative summary/review (non-systematic) 3 (5%) [58–60]
Framework or Experts recommendations 3 (5%) [3,61,62]
Editorial or Letter to the editor 3 (5%) [15,63,64]
Non-empirical (peer-reviewed): SUB-TOTAL 41 (73 %) -
Cross-sectional surveys 4 (7%) [65–68]
Systematic analysis of electronic medical/
administrative records 2 (4%) [69,70]
Ecological study 2 (4%) [71,72]
Systematic review 1 (2%) [73]
Analysis of COVID-19 press conferences 1 (2%) [74]
Analysis of webpages on accessibility compliance 1 (2%) [75]
Documentary research and framework analysis 1 (2%) [6]
Case report (4 patients) 1 (2%) [76]
Empirical studies (peer-reviewed): SUB-TOTAL 13 (23%) -
Ecological study 1 (2%) [77]
Observational multicenter study 1 (2%) [78]
Preprint studies: SUB-TOTAL 2 (4%) -
Geographical Focus





United States of America (USA) 9 (15%) [27,56,57,59,67,70,72,73,77]
United Kingdom (UK) 5 (8%) [16,40,45,61,78]
Latin America 2 (4%) [6,64]
Low- and Middle-Income countries (LMICs) 1 (2%) [74]
South Africa 1 (2%) [38]
India 1 (2%) [66]
Romania 1 (2%) [30]
Italy 1 (2%) [65]
Health Conditions





Adults with cognitive impairment (e.g., dementia) or
intellectual disabilities 8 (14%) [36,42,45,52,55,61,64,71]
People with disabilities living in residential or
long-term facilities 3 (5%) [30,70,78]
Spinal cord injury 3 (5%) [37,58,68]
Children with disabilities (overall) 2 (4%) [27,41]
Older adults experiencing disabilities 1 (2%) [46]
People with developmental disabilities (overall) 1 (2%) [69]
Visual impairments 1 (2%) [33]
Autism spectrum disorder 1 (2%) [28]
Cerebral palsy 1 (2%) [29]
Cerebellar ataxia 1 (2%) [62]
Down’s syndrome 1 (2%) [76]
Severe mental illness 1 (2%) [66]
Multiple sclerosis 1 (2%) [65]
Rheumatoid arthritis 1 (2%) [60]
Int. J. Environ. Res. Public Health 2021, 18, 4348 7 of 17
In the sections below, we provide the descriptive thematic analysis of any dispropor-
tionate health risks or consequences experienced by people with disabilities.
3.1. People with Disabilities Living in Residential or Long-Term Care Facilities Were More Likely
to Have Greater Infection Rates
Greater COVID-19/SARS-CoV-2 infection rates among people with disabilities living
in residential or long-term care facilities were reported by included studies or review
of studies.
Using data for people with intellectual and developmental disabilities from a coalition
of organizations providing over half of the residential services for the state of New York,
and from the New York State Department of Health, the COVID-19/SARS-CoV-2 case rate
for people with intellectual and developmental disabilities was found to be over four times
greater than for the New York State general population, likely due to the high percentage
of those who live in congregated care settings [70]. However, the interpretation of these
numbers needs to account for the incipient health surveillance data focused on people
with intellectual and developmental disabilities, which can result in limited reporting on
COVID-19 outcomes for this population [70].
Similarly, a narrative review of overall health inequities has found evidence showing
that people with disabilities living in residential facilities can have a five times greater
likelihood of being infected by the SARS-CoV-2 than the general population [59]. In resi-
dential facilities for people with severe epilepsy, enhanced surveillance revealed high rates
of asymptomatic SARS-CoV-2 infected residents (from 56 to 78% in varying residencies),
for a relatively low (9%) symptomatic infection rate; this finding highlights how easily the
infection can spread in these contexts, including through asymptomatic cases [78]. Finally,
a literature review found a high rate of dementia in cases of people hospitalized with
COVID-19 (values varied from 6.8 to 13.1% across studies) [71], while the WHO estimates
a 5–8% prevalence of dementia for the population aged over 60.
For people with disabilities living in the community, the few and only partly related
existing data pointed in an opposite direction. In a pre-print ecological study of the non-
institutionalized disabled population, within the most affected counties of the United States
and up to 9 April 2020, the bivariate regression analyses indicate that counties with a higher
White disabled population (95% CI: −0.43-(−0.02); p-value: 0.03), higher population with
hearing disability (95% CI: −0.42- (−0.11); p-value: 0.001.2), and higher population with
disability in the 18−34 years age group (95% CI: −0.41-(−0.09); p-value: 0.002) had a lower
rate of SARS-CoV-2 infection—yet higher mortality rates as later depicted [77]. However,
these data are from an ecological study with the main unit of analysis on counties and their
population strata rather than on people with disabilities themselves.
3.2. Intersecting Mediators of Greater Infection Risks
The literature reviewed revealed a myriad of causes explaining why people with
disabilities may experience greater infection risks, and notably far greatest infection rates
observed among institutionalized people with disabilities.
In residential care settings, shielding and self-isolation were difficult during the first
wave of the pandemic. This was due to the: initial unpreparedness of the facilities at
the pandemic outset, shared use of essential living spaces, crowding and shared rooms,
proximity to other residents, residents’ difficulty understanding new rules imposed sud-
denly, difficulty in maintaining standards of hygiene during home visits, multiple shift
staffing patterns, staff working in multiple settings, and high levels of personal care
assistance required from staff (e.g., with eating, toileting, or transferring from bed to
wheelchair) [16,30,31,36,38,39,43,51,53,54,59,70,78]. Indeed, stemming from the latter rea-
son, many articles pointed out that a wide range of people with disabilities who rely on
assistants for basic activities of daily living have greater risks of infection [6,32,36,41,49].
Regarding impairment subgroups, people with intellectual, developmental, or cog-
nitive impairments (e.g., from dementia), either institutionalized or not, might not un-
derstand, remember, or be able to systematically comply with the quarantine or other
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preventive measures (e.g., use of masks, washing hands, and physical distancing), and
may even respond with challenging behavior including motor agitation, intrusiveness,
or wandering, which may undermine efforts to maintain isolation and other preventive
measures [36,40,42,52,55,62,71,78].
Among persons with severe mental illness, 8 to 23% were not aware of the ongoing
COVID-19 pandemic, the need for quarantine, or the mode of spread of COVID-19, either
due to cognitive impairments or lack of access to information from the media; therefore,
unlike the general population, about 75% of the persons with severe mental illness did
not report fear of contracting COVID-19 and may not have taken protective measures [66].
People with intellectual and cognitive disabilities may have difficulties identifying or
communicating that they are experiencing mild symptoms, and this can help justify the
high rates of seemingly asymptomatic cases observed in a residential setting for people
with disabilities [78].
People with visual or hearing impairments also may face infection risk because of
a lack of accessible information on preventive measures during the initial stages of the
pandemic. [16,48–50] In Low- and Middle-Income Countries (LMICs), the situation can be
worse [49]. For instance, an audit of press conferences in LMICs showed that only 65% of
countries have used a sign language interpreter, with figures varying from 33% to 88% [74].
Globally, another analysis showed that pages of the World Health Organization’s website,
March–May 2020, were only 60% compliant regarding web accessibility guidelines [75].
Additionally, people with sensory processing and visual impairments may need to rely or
depend on touch and tactile senses for stimulus or to perform their routine activities or
outdoor movement, and thereby face greater infection risks [33,38,40,43,49].
For people with Down Syndrome, increased cytokine production can make them
vulnerable to contracting infections like COVID-19, with insufficient immunity after disease
recovery and a possible higher risk of reinfection, or even lower immune response to
vaccination [76].
Focusing on environmental circumstances, in Latin America, millions populate densely
packed ‘favelas’ in which large families often share a single room, and many consider
moving a grandparent to a nursing home inconceivable; hence, older people and those with
disabilities are quarantined within crowded living quarters, where they can be exposed
to asymptomatic carriers [64]. Moreover, in LMICs, many people with disabilities lack
access to clean water, live in crowded institutional settings, and have added difficulties
complying with hand hygiene, physical distancing, and other protective measures [38].
Children with disabilities often rely heavily on ride-sharing programs for transporta-
tion to school and other activities; these modes of transport compel more exposure than
private transportation [27]. Prevalence of disabilities is also high for incarcerated people,
where rates of COVID-19 infection and transmissions have been great [3].
Finally, the results of survey research in Italy may help explain why some groups of
people with disabilities living in the community may have been less exposed to a COVID-19
infection. The study showed generally good adherence of persons with Multiple Sclerosis
(n = 551) to lockdown and extensive use of protection devices, as measured by Lockdown
Scores [65]. Overall, the authors found that women, older persons, persons with disabilities,
and those who were unemployed had higher Lockdown Scores (p < 0.05) [65]. It is possible
though, that this can arise from the combination of greater cautions due to the fear of the
greater health consequences of an infection as well as lower social participation levels.
3.3. People with Disabilities often Face Greater Health Consequences When Infected
In a study using a large dataset from electronic medical records of a COVID-19
Research Network, the case-fatality rate was much higher for people with intellectual and
developmental disabilities compared to non-disabled counterparts at younger ages such as
<17 (1.6% versus 0.01%) and 18 to 74 years (4.5% versus 2.7%), even though similar (5.4%
versus 5.1%) for all ages [69], possibly reflecting greater prevalence of comorbidities among
people with disabilities relative to non-disabled counterparts at younger ages [69].
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In one ecological study of the associations between infection and mortality rate of
COVID-19 and demographic, socioeconomic, and mobility variables from 369 counties in
the USA, a higher rate of people with disability in the county was significantly associated
with higher mortality (95% CI: 0.09–0.45) [72]. In turn, the same study found that while
poverty and disability are frequently associated, their interaction was not significant
(p = 0.469) and could have had independent contributions as risks to mortality [72].
In New York state, a case-fatality rate of 15% among people with intellectual or de-
velopmental disabilities was about double of the general population [70]. In residential
facilities for people with epilepsy in the UK, the case fatality rate was high (50% or 11%
corrected for asymptomatic) [78]. An ecological study found significant correlations be-
tween Disability-Adjusted Life Years from dementia with COVID-19 mortality [71], which
is aligned with the results of underlying literature reviewed indicating that pre-existing
dementia was significantly associated with COVID-19 severity and increased mortality
rate [71].
People with rheumatoid arthritis are intrinsically characterized by an increased in-
fectious risk due to the disease itself and to the iatrogenic effect of immunosuppressive
agents such as corticosteroids [60]. In persons with Down Syndrome, increased cytokine
production (e.g., COVID-19 mortality also accounts for cytokine release syndrome), more
vulnerable immune systems, and frequent comorbidities like diabetes, heart, and respira-
tory conditions, can all make these persons vulnerable to mortality and other deleterious
consequences of infections like COVID-19 [34,35,76]. Individuals with Cerebral Palsy also
frequently experience comorbidities such as pulmonary disease or elevated blood pres-
sure [29]. In people with cerebellar ataxia, dysphagia, or ataxic respiration, the maintenance
of airway protection, and aspiration pneumonia are ever-present concerns, with COVID-19
infections adding to pulmonary complications [67].
For individuals with spinal cord injury, several special considerations apply. Physio-
logical changes not only increase their risk of morbidity from COVID-19 but may also mask
the presentation of acute respiratory illnesses and delay the diagnosis of COVID-19, while
individuals with cervical or high thoracic spinal cord injuries may not have chest sensations
or the ability to cough [37,58,63]. In an international survey of healthcare professionals
who care for those with spinal cord injury (n = 783), 10.3% reported their patients with
COVID-19 had increased spasticity and 6.9% reported that their patients had rigors [68].
Patients with dementia who develop COVID-19 also may present atypical symptoms,
such as delirium, rather than respiratory symptoms, which also affect the early recogni-
tion [71]. In turn, people with intellectual disabilities overall might be unable to identify or
report infection symptoms [31,61].
Individuals with impaired mobility, including people with visual impairments, may
not be able to access drive-through COVID-19 test facilities for early detection of the
disease [49]. In turn, people with intellectual disabilities, as well as deaf and hard-of-
hearing individuals, are unable to use many of the complex, non-inclusive automatic
answering systems to access COVID-19 screenings [49]. Furthermore, the non-visitor
policies at treating hospitals might impede a caregiver-mediated information exchange and
shared decision-making on critical care decisions for people with intellectual disabilities,
while structural issues such as inaccessible facilities and equipment, existing for decades,
impede optimal COVID-19 diagnostic and treatment for people with disabilities [49]. In
China, during the COVID-19 quarantine, one disabled teenager died after being left at home
for six days without care, while his relatives were quarantined, which can illustrate how
needed acute healthcare may be inaccessible for unsupported people with disabilities [32].
Overall, in addition to any associated comorbidities, poorer outcomes for people with
disabilities can come from difficulty to detect or communicate the infection symptoms as
well as from the restricted or delayed access to essential public health information and
life-saving healthcare [15,16,30,31,36,42,54,61,72,77].
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3.4. The Unethical Disadvantage in the Rationing of Lifesaving and Critical Care
In a systematic review of Crisis Standards of Care across USA states, it was found that
only two-thirds explicitly articulated that resource allocation decisions should be made
without regard to race, ethnicity, disability, and other identity-based factors [73]. The same
review found that low likelihood of immediate survival was frequently stated for exclusion,
including examples such as “advanced” and/or “irreversible” neurologic events or “severe
dementia” (70% of states had these exclusion criteria) [73], while a neurologic disorder
(e.g., Alzheimer’s dementia) was one the most frequently cited health conditions to be
considered for low prioritization decisions (33.3%) [73].
Other published accounts point out that, in the USA, some states were endorsing
guidelines to withhold ventilators and treatment from those with certain neurological
impairments and intellectual disabilities [53,56,59,62]. In some jurisdictions, policies have
been issued for people with disabilities to have a lower priority to receive critical and
lifesaving medical care; at a very minimum, confusion around this (or lack of clear state-
ments otherwise) could further limit access to lifesaving care for people with disabili-
ties [6,28,44,46,48,53,56]. For example, guidelines stating that survival of younger healthy
persons is to be prioritized relative to “chronically debilitated patients” can be interpreted
to disadvantage people with disabilities, even if young or otherwise healthy [53]. Fi-
nally, beyond ethically questionable, explicitly excluding people based on disability and is
probably illegal under anti-discrimination laws [56].
Medical rationing decisions based on markers such as ‘quality of life’ may lead
healthcare providers to discriminate against disability due to preconceived (and often
without awareness) ableist notions about people with disabilities’ quality of life [13,44,47,
53,56]. Physicians and health care providers may well be influenced by implicit and explicit
ableism [39]. Stereotypes about what life is like living with a disability can be improperly
used to exclude people from needed care [35,49]. Healthcare providers in the field, forced
to make rapid decisions, sometimes in the absence of guidelines, will inevitably bring
societal and personal ableist biases—with or without awareness—into the triage process
which, if unchecked, may result in stark inequities in both care and survival for people with
disabilities at the population level [73]. Ethical issues surrounding priority vaccination
and treatments are likely to affect the health impact of the COVID-19 in the disability
community [34].
Some guidelines for access to critical care would imply, or be interpreted, as a form
of disablism or social utilitarian perspective, by directly or indirectly excluding (younger)
people with disabilities but otherwise healthy and no less likely than other people of
the same age to recover with treatment, when impairments per se often have no impact
on the likelihood of survival [12,56]. Furthermore, people with disabilities that require
permanent ventilation to live may be threatened by the lack of ventilators to respond to the
pandemic [27,57].
The pandemic is prompting healthcare providers to think more about rationing, which
may result in the devaluing of the lives of patients with compromised decision-making
capacity (e.g., cognitively impaired) [45]. Furthermore, in the context of a pandemic, time
and other pressures on healthcare providers may impede their ability to carry out capacity
assessments in full, notably to judge whether one person has the cognitive capacity to take
or participate in critical medical decisions [51]. People with intellectual disabilities may
become subject to rationing and the non-use of potential lifesaving treatments, as merely
assumed by providers [61].
In South Africa, accounts of utilitarian COVID-19 triage policies and practices have
been found, disadvantaging many people with disabilities, especially people with physical
and intellectual impairments, from gaining intensive care unit access, while not providing
care on a utilitarian basis, e.g., factoring in the patient’s cognitive impairment is argued
to be against the United Nations Convention on the Rights of Persons with Disabilities
(UN-CRPD) [38,51]. In the UK, there was a higher threshold for frail elders and those with
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so-called challenging behavior in long-term care to be admitted to hospitals, as well as
their access to intensive care was restricted [78].
Overall, during the first wave of the pandemic, people with disabilities were worse-off
compared to their non-disabled peers in terms of risk factors for more severe outcomes and
faced an often inaccessible healthcare system with a history of ableism and discrimination
against people with disabilities. In particular, there is an absence of consolidated guidelines
for emergency responses that are explicitly free of disability stigma or bias [50].
4. Discussion
This scoping review addresses the literature published during the initial stages of
the COVID-19 pandemic (up to mid-September 2020), and the results suggest that people
with disabilities can experience disproportionate health risks and consequences from a
COVID-19 infection. These disparities can result from several intersecting factors. On
the one hand, health-related factors such as greater comorbidity rates among younger
people with disabilities, compared to non-disabled counterparts, may justify the much
greater fatality rates observed for that subgroup of people with disabilities. On the other
hand, several environmental factors contributed to turning many people with disabilities
vulnerable to a COVID-19 infection or their consequences. These include multiple exposure
risks in residential or long-term facilities, the lack of accessible healthcare and information,
and medical rationing decisions influenced by disability stigma. Indeed, environmental
determinants of transversal nature (e.g., related to disability stigma, health information
and healthcare access disparities, and lack of systemic accommodations) may help justify
the fact that most papers address people with disabilities in general and not by specific
conditions. While the identified environmental determinants of dispositional health risks
and consequences are potentially modifiable, addressing them would promote health
equity for people with disabilities.
In residential or long-term facilities, multiple infection risk factors such as the shared
use of spaces, staff working in multiple settings, high levels of personal care assistance
from staff (especially for residents with disabilities), among other risk factors synthesized
in this review, were coupled with settings’ initial unpreparedness to manage a pandemic,
to create a ‘perfect storm’, disproportionately impacting on people with disabilities, who
are overrepresented in these settings. Therefore, there is a need for disability-inclusive
systematic preparedness and rapid responses to pandemic events [6,15–17,79], which shall
include a focus on residential or long-term settings and engage people with disabilities or
their representatives in the development process [7,31,32,34,38,40,80]. Research evidence
and equitable perspectives on vulnerabilities faced by people with disabilities, such as
the ones here synthesized, can also inform the development of disability-inclusive re-
sponses and preparedness plans—to a pandemic or overall disaster, crisis, or emergency
events. Future plans for a disability-inclusive preparedness and response might also be
designed to account for (e.g., include counter-measures for preventing or mitigating) any
unintended consequences of the infection prevention measures. These may include so-
cial distance and loneliness, confusion, lack of (physical) activity, unmet personal needs,
among other lockdowns- or quarantine-related vulnerabilities experienced by people with
disabilities during the COVID-19 pandemic. These were further synthesized in a second
paper resulting from this scoping review project [19].
The lack of accessible information (e.g., in press conferences, public health websites)
was another modifiable environmental factor identified as a barrier to health equity for
people with disabilities. This can be addressed with the straight application of existing
guidelines, e.g., web-accessibility guidelines [75], the presence of sign language interpreters,
and the use of transparent masks for the transmission of key public health information.
Principles of health literacy [81] might also be useful for optimizing the access to and
understanding of the needed preventive measures, for example, but not limited to, among
people with developmental, intellectual, or cognitive impairments, as well as their care-
givers. COVID-19 test facilities and automatic answering systems to access COVID-19
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screenings might also be designed or modified to be accessible by all, including people
with disabilities.
The unethical disadvantage in the rationing of lifesaving and critical care, associated
with disability stigma or stereotypes of poor quality of life among people with disabilities,
was another major environmental barrier synthesized from the reviewed literature. This
barrier can reflect socially entrenched misconceptions, discrimination, and prejudice toward
people with disabilities [7,15,80], and was operationalized during the initial pandemic
time through triage guidelines and medical decisions at least implicitly biased against
people with disabilities. While the reviewed literature reports that some triage guidelines
explicitly state that medical decisions should not be based on factors such as a presence or
absence of a disability, many others either fail to address it or at least implicitly suggest
otherwise [73]. When not explicitly stated that disability should not be equated as a factor,
ableist preconceptions of medical staff may result in judging the value of a people with
disabilities as one least worth living. It is important to acknowledge that impairments per
se are not akin to comorbidities and that the former might not objectively interfere with
chances of survival from a COVID-19 infection [12,56,57].
Medical decisions and triage guidelines explicitly free of disability stigma is an ethical
and legal matter, i.e., both the ‘right’ and lawful thing to do [38,51,56]. More recently,
ethical and legal issues can be posed around the issue of who, including people with
disabilities, shall be prioritized for COVID-19 vaccination [82]. The UN-CRPD serves as
a human rights ground for anti-discrimination laws and care directives. Aligned with
this, for example, the Office for Civil Rights in the US has issued guidance to States and
healthcare providers, early during the pandemic, stating that disability rights and anti-
discrimination laws are not waived during the pandemic [83]. Furthermore, in person or
remotely involving diverse people (e.g., disability activist or scholars, ethicists, healthcare
providers with disabilities, rehabilitation professionals, and others more likely aware of
disability rights), in reviewing or taking collective life-saving medical decisions, may
reduce the likelihood of personal biases in medical rationing decisions [48,49]. For the
development of equitable guidelines, people with disabilities or their advocates might be
actively involved. Additionally, factors synthesized here (e.g., vulnerabilities of people with
disabilities living in residential facilities, insufficient immunity in individuals with Down
Syndrome) can also be taken into consideration in terms of prioritizing the most vulnerable.
Finally, we have found that few papers had a specific focus on LMICs, and even
though some specific issues may apply and have been described (e.g., greater infection-
spread risks through large conglomerates of people in ‘favelas’ or households), others
are less well-addressed. People with disabilities living in LMICs can face multiple health
and social disparities [17,84,85], and being among the least studied can also contribute to
that. Further data and studies on the disproportionate impact of the COVID-19 pandemic
on people with disabilities in LMICs are warranted, especially considering that health
systems and structures often differ substantially from those in high-income nations and
provided that the health needs of people with disabilities living in LMICs all unmet all too
often [85–87].
Limitations
This paper has the following limitations: First, this paper only reviewed the informa-
tion available up to mid-September 2020. A continuous update of the searches was found
unfeasible as the increasing trend in the number of retrieved references was outpacing
our planned capacity to timely process them. We opted to review a defined timespan
and not to compromise on key methods, such as the use of two independent reviewers,
because eligibility and extraction decisions were not always straightforward, e.g., on the
interpretation of whether any special vulnerability was involved, and the input of a third,
expert reviewer was often involved. Another reason to limit the timespan was that it per-
mitted the involvement of multiple co-authors with diverse backgrounds in the synthesis,
including experts in consultation roles. Their collective input enhanced the interpretation
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of the findings reported in this article. Since only papers available before mid-September
2020 were included in the review, these results are limited to the initial stages of the
pandemic, where the impact of unpreparedness may hit harder. Review updates, with a
priori hypotheses, more focused study questions, and eligibility criteria, can eventually
occur; informing more focused reviews (e.g., a systematic review) is one of the typical
purposes of conducting scoping reviews in the first place [22,23]. In a rapid scan of the
literature published after mid-September 2020, we detected a study detailing the deaths
among people with intellectual disabilities in the UK and Ireland [88]. That study coincides
with our findings and found, for instance, that younger people with disabilities can be
at risk of adverse consequences, given the younger mean age of death due to COVID-19
of individuals with intellectual disability relative to the mean age of death in the general
population [88].
Second, few empirical studies addressing the health risks and impact of COVID-19
infection on people with disabilities were found, which aligns with the results of a recent
rapid review of the literature [89]. On the one hand, this may be due to the little time
to conduct and publish studies up to mid-September 2020; in the paragraph above, we
provided an example of one additional study published afterward. On the other hand,
it may also reflect the fact that disability status is not systemically included in health
surveillance systems or electronic medical or administrative records [34,48,54,90]. This lack
of readily available data, and especially so in LMICs, may have undermined the ability to
produce rapid studies on any disproportionate effects of the COVID-19 infection on people
with disabilities. Furthermore, articles, in contrast to editorials, letters, commentaries,
typically take more time to peer-review, which was part of the reason why preprint studies
were considered in this review [21]. Designing, funding, and developing inclusive COVID-
19 research is a necessity, not a luxury. Under this approach, a recent project provided
a framework and checklists for addressing key issues when designing and delivering
COVID-19 research, inclusive of vulnerable groups such as people with disabilities [91].
Third, we excluded grey literature since a key repository of that information was
found (https://www.un.org/development/desa/disabilities/covid-19.html (Accessed
date: 15 December 2020)) and this decision allowed for timelier results. Of note, many
perspective papers included in this study had already considered and integrated the
content of the grey literature. However, as the grey literature was not included, we cannot
determine whether our results overall, and our themes, in particular, would have differed
otherwise. Although the perspective papers included are not empirical papers, they were
peer-reviewed (i.e., had scrutiny by other experts) and provided key qualitative accounts,
reported experiences in some countries, discussed key ethical perspectives and threats, and
other important information that contributed to these findings and provided context to
help interpret the data from various studies.
Fourth, no methodological quality assessments were performed, as it is common in
scoping reviews. Hence, we cannot assure whether reported study findings result from
scientifically sound methodological processes. Further, up-to-date systematic reviews on
specific topics here explored (e.g., increased infection or death rates among people with
disabilities living in residential or long-term care settings) should provide more trustable
results (i.e., involving risk-of-bias assessments) for these particular findings.
Fifth, little and somewhat inconclusive data was found on any disproportionate
infection rates among people with disabilities living in the community. As an exception,
one study showed that community-dwelling people with disabilities extensively used
protection devices, as measured by Lockdown Scores, similar to women, older persons,
and those who were unemployed [65]. It is possible that lower social participation levels
of these often marginalized or vulnerable groups may temporarily protect people with
disabilities living in the community from infection risks, but exacerbates other structural,
social, and even health disparities (other than from a COVID-19 infection), which are
addressed in our second paper [19].
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5. Conclusions
This scoping review, addressing the initial stages of the COVID-19 pandemic, suggests
that people with disabilities can experience disproportionate health risks and consequences
from a COVID-19 infection. These risks and disparities are challenging and go beyond any
health-related vulnerabilities (e.g., the greater presence of comorbidities among younger
people with disabilities relative to non-disabled counterparts), and in fact entail multiple
environmental factors. These include, for example, multiple exposure risks for people with
disabilities who live in residential facilities, lack of accessible healthcare and information,
and medical rationing affected by ableism and disability stigma. These environmental
determinants of disparities can, and should, be modified to prevent or mitigate any dis-
proportionate health risks and consequences of a COVID-19 infection for people with
disabilities worldwide.
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